Parkinson’s Disease / 2019 / Article / Tab 1

Research Article

Emotional Processing Impairments in Apathetic Patients with Parkinson’s Disease: An ERP Study in Early Time Windows

Table 1

Demographic and neuropsychological data of PD patients and HCs.

Apathetic groupNonapathetic groupHC

Age64.93 ± 6.4763.48 ± 6.4063.76 ± 6.420.778
Sex (male), n (%)10 (66.7)18 (72)14 (61.9)0.907
Education (yr)8.67 ± 3.567.80 ± 3.378.76 ± 2.980.753
Hoehn–Yahr stage2 (1–3)2 (1–3)
UPDRS18.99 ± 4.2217.31 ± 5.17
BDI-II5.47 ± 2.135.44 ± 2.224.33 ± 1.680.133
SAS20.33 ± 4.347.92 ± 2.314.71 ± 1.95<0.001
Disease duration6.47 ± 2.266.36 ± 1.35
L-DOPA daily dose (mg)476.47 ± 78.98454.80 ± 89.61
Test scores
MoCA28.00 ± 1.3127.56 ± 1.3628.33 ± 1.710.215
Digit span forward7.33 ± 1.057.36 ± 1.788.48 ± 2.110.068
Digit spEan backward3.60 ± 1.183.68 ± 1.074.33 ± 0.910.060
TMT (seconds)
Part A76.40 ± 15.7163.40 ± 12.8151.71 ± 10.04<0.001
Part B188.47 ± 28.05163.28 ± 33.32142.00 ± 23.04<0.001
Word Fluency15.06 ± 3.5614.44 ± 3.4016.38 ± 2.670.129

Comparison of demographic data, clinical variables, and neuropsychological tests among the three groups. UPDRS, Unified Parkinson’s Disease Rating Scale; BDI-II, Beck Depression Inventory II; SAS, Starkstein Apathy Scale; MoCA, Montreal Cognitive Assessment; TMT, Trail-Making Test.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.